141 related articles for article (PubMed ID: 34505493)
1. [A woman in her eighties with chest pain during immunotherapy for melanoma].
Karlsen TLS; Karlsen J; Mo R; Hammer T
Tidsskr Nor Laegeforen; 2021 Sep; 141(2021-12):. PubMed ID: 34505493
[TBL] [Abstract][Full Text] [Related]
2. Acute motor axonal neuropathy after ipilimumab and nivolumab treatment in melanoma brain metastases: A case report and review of the literature.
Piña Y; Evernden BR; Khushalani N; Margolin K; Tawbi H; Tran ND; Macaulay R; Forsyth P; Peguero E
SAGE Open Med Case Rep; 2021; 9():2050313X211042215. PubMed ID: 34457306
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy-induced severe neutropenia with neurotoxicity: A case of a 75-year-old woman with ulcerative colitis diagnosed with melanoma.
Patel R; Pai L
J Oncol Pharm Pract; 2020 Apr; 26(3):730-734. PubMed ID: 31315551
[TBL] [Abstract][Full Text] [Related]
4. Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report.
Monge C; Maeng H; Brofferio A; Apolo AB; Sathya B; Arai AE; Gulley JL; Bilusic M
J Immunother Cancer; 2018 Dec; 6(1):150. PubMed ID: 30563577
[TBL] [Abstract][Full Text] [Related]
5. Myasthenia gravis induced by nivolumab in patients with non-small-cell lung cancer: a case report and literature review.
Hasegawa Y; Kawai S; Ota T; Tsukuda H; Fukuoka M
Immunotherapy; 2017 Aug; 9(9):701-707. PubMed ID: 28649876
[TBL] [Abstract][Full Text] [Related]
6. Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
Tanaka R; Maruyama H; Tomidokoro Y; Yanagiha K; Hirabayashi T; Ishii A; Okune M; Inoue S; Sekine I; Tamaoka A; Fujimoto M
Jpn J Clin Oncol; 2016 Sep; 46(9):875-8. PubMed ID: 27380808
[TBL] [Abstract][Full Text] [Related]
7. Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report.
Takeno A; Yamamoto M; Morita M; Tanaka S; Kanazawa I; Yamauchi M; Kaneko S; Sugimoto T
BMC Endocr Disord; 2019 Feb; 19(1):25. PubMed ID: 30782163
[TBL] [Abstract][Full Text] [Related]
8. Acute hypophysitis secondary to nivolumab immunotherapy in a patient with metastatic melanoma.
Kuru S; Khan N; Shaaban H
Int J Crit Illn Inj Sci; 2017; 7(3):177-180. PubMed ID: 28971033
[TBL] [Abstract][Full Text] [Related]
9. [A case of myasthenia gravis and myositis induced by nivolumab].
Konoeda F; Suzuki S; Nishimoto Y; Hoshino H; Takagi M
Rinsho Shinkeigaku; 2017 Jul; 57(7):373-377. PubMed ID: 28674287
[TBL] [Abstract][Full Text] [Related]
10. Cogan-Like Syndrome Following Nivolumab Immunotherapy for Metastatic Cutaneous Melanoma.
Philip AM; Fernandez-Santos CC; Dolinko AH; Massoudi Y; Valerio T; Maleki A; Foster CS
Ocul Immunol Inflamm; 2024 Jun; ():1-5. PubMed ID: 38913501
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy-associated autoimmune hemolytic anemia.
Khan U; Ali F; Khurram MS; Zaka A; Hadid T
J Immunother Cancer; 2017; 5():15. PubMed ID: 28239468
[TBL] [Abstract][Full Text] [Related]
12. Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma.
Bottlaender L; Breton AL; de Laforcade L; Dijoud F; Thomas L; Dalle S
J Immunother Cancer; 2017 Jul; 5(1):57. PubMed ID: 28716106
[TBL] [Abstract][Full Text] [Related]
13. Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: case report and literature review.
McDonald MA; Sanghvi P; Bykowski J; Daniels GA
BMC Cancer; 2018 May; 18(1):549. PubMed ID: 29743050
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy associated pain crisis and the haemophagocytic lymphohistiocytosis syndrome in advanced melanoma: Case report and review of the literature.
Krasovitsky M; Borbasi J
Palliat Med; 2021 May; 35(5):972-976. PubMed ID: 33761792
[TBL] [Abstract][Full Text] [Related]
15. Hepatic Injury Induced by a Single Dose of Nivolumab - a Case Report and Literature Review.
Kopecký J; Kubecek O; Geryk T; Podhola M; Ziaran M; Priester P; Hanisova M; Borilova S
Klin Onkol; 2019; 32(2):133-138. PubMed ID: 30995854
[TBL] [Abstract][Full Text] [Related]
16. Severe Myositis, Myocarditis, and Myasthenia Gravis with Elevated Anti-Striated Muscle Antibody following Single Dose of Ipilimumab-Nivolumab Therapy in a Patient with Metastatic Melanoma.
Fazel M; Jedlowski PM
Case Reports Immunol; 2019; 2019():2539493. PubMed ID: 31183226
[TBL] [Abstract][Full Text] [Related]
17. Primary malignant melanoma of the esophagus successfully treated with nivolumab: a case report.
Ito S; Tachimori Y; Terado Y; Sakon R; Narita K; Goto M
J Med Case Rep; 2021 May; 15(1):237. PubMed ID: 33947459
[TBL] [Abstract][Full Text] [Related]
18. "Eye-Black" Sign Secondary to Nivolumab Immunotherapy.
Priya S; Graham M
Clin Nucl Med; 2020 Mar; 45(3):217-219. PubMed ID: 31876808
[TBL] [Abstract][Full Text] [Related]
19. Dermatomyositis in a patient undergoing nivolumab therapy for metastatic melanoma: a case report and review of the literature.
Kosche C; Stout M; Sosman J; Lukas RV; Choi JN
Melanoma Res; 2020 Jun; 30(3):313-316. PubMed ID: 31567590
[TBL] [Abstract][Full Text] [Related]
20. Nivolumab: Immunotherapy in Malignant Melanoma.
Bayless H; Schneider S
Clin J Oncol Nurs; 2015 Aug; 19(4):430-2. PubMed ID: 26207707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
